Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients

Loskog A, Maleka A, Mangsbo S, Svensson E, Lundberg C, Nilsson A, Krause J, Agnarsdóttir M, Sundin A, Ahlström H, Tötterman TH, Ullenhag G

Br J Cancer 114 (8) 872-880 [2016-04-00; online 2016-03-31]

Clinical Biomarkers [Service]

QC bibliography QC xrefs

DOI 10.1038/bjc.2016.42

Crossref 10.1038/bjc.2016.42